2014 World Congress of the International Federation of Head and Neck Oncologic Societies

Advertisement

Advertisement



Aug
17
Today In Oncology
FDA Approves Lenvatinib for Unresectable Hepatocellular Carcinoma
Issues in Doctor-Patient Discussions on Potential Harms of Lung Cancer Screening
VB4-845 Granted Fast Track Designation by FDA for Treatment of Non–Muscle Invasive Bladder Cancer
Basal Cell Carcinoma and Risk for Development of Other Cancers
Broad-Based Genomic Sequencing in Advanced NSCLC in the Community Oncology Setting
View More 
;
Advertisement
Most Read Stories
Enzalutamide Prolongs Metastasis-Free Survival in Patients With Nonmetastatic, Castration-Resistant Prostate Cancer
New Frontiers Being Explored in Multiple Myeloma
No Benefit of Adding Abiraterone to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Increasing PSA
Apatinib and Oral Etoposide in Platinum-Resistant/Refractory Ovarian Cancer
Long-Term Pooled Safety Data for Palbociclib Combined With Endocrine Therapy in HR-Positive, HER2-Negative Breast Cancer
View More 
Most Viewed Videos
Gilberto Lopes, MD, MBA, on NSCLC: Results From the KEYNOTE-042 Trial
Gabriel N. Hortobagyi, MD, on Breast Cancer Staging: New and Important Changes
Jonathan W. Friedberg, MD, on Follicular Lymphoma: Novel Combination Therapies
Melinda Telli, MD, on Triple-Negative Breast Cancer: New Clinical Approaches
Sherry Shen, MD, on Breast Cancer and Obesity: Results of the SWOG S0927 Study
View More 
© 2018 HSP News Service, L.L.C.
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.